Inebilizumab Antibody
Inebilizumab is a humanized monoclonal antibody targeting CD19, designed to deplete B cells via enhanced antibody-dependent cellular cytotoxicity. It is utilized in research on autoimmune conditions like neuromyelitis optica spectrum disorder and multiple sclerosis, with applications in both in vitro B cell assays and in vivo disease models.
Product Specifications
Product Name Alternative
VIB 0551, VIB0551, VIB-0551, Inebilizumab, MT0551, MT-0551, MT 0551, MEDI551, MEDI-551, MEDI 551, 16C4-aFuc, ADC Antibody, ADCAntibody
Target
ADC Antibody, Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
3.19 mg/mL
Purity
96.20% (May vary between batches)
Molecular Weight
146.60 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker) (CPA1/2712), CF647 conjugate, 0.1mg/mL
Heat Shock 27kDa Protein 1 (HPS27) (CPTC-HSPB1-2), 0.2mg/mL
Recombinant MERS-CoV Spike/RBD Protein fragment (RBD, aa 367-606, rFc Tag)
![Tide Quencher™ 2WS maleimide [TQ2WS maleimide]](https://cdn.genprice.uk/products/271/7359022/imageurl/2059-aat.webp)